U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines. Geneva: World Health Organization; 2019.

Cover of Risk Reduction of Cognitive Decline and Dementia

Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines.

Show details

Evidence profile: Weight reduction and cognitive decline or dementia

Scoping question:

For adults with normal cognition or mild cognitive impairment who are overweight or obese, are interventions for weight reduction (or control of obesity) more effective than usual care or no intervention in reducing the risk of cognitive decline and/or dementia?

Background

As the number of older adults increases worldwide, a rise in dementia and Alzheimer’s disease (AD) has also been reported,1 causing health, economic and social burdens.2,3 In 2015, it has been estimated that there were 46.8 million people with dementia in the world, and the number is predicted to double every 20 years, reaching 74.7 million in 2030 and 131.5 million in 2050.1 AD/dementia has been linked to modifiable, lifestyle-related, cardiovascular risk factors (CVRFs),14 and since the management of CVD is still suboptimal in many countries, especially among older adults and no cure is available for AD, CVRFs management could be crucial in halting the rapid increase in the prevalence of dementia, as some projection models suggested.5,6

Overweight and obesity is one of the best characterised and established risk for a variety of non-communicable diseases, the cause of at least 2.8 million deaths each year world-wide, and of an estimated 35.8 million (2.3%) of global DALYs.7 in 2008, 35% of adults aged 20+ were overweight (BMI ≥ 25 kg/m2) (34% men and 35% of women) with significantly variable prevalence among world areas, being the Americas, Europe, and the Eastern Mediterranean the regions with the highest concentration of overweight and obese people.7 Overweight and obesity, in particular, has been linked to a number of medical complications such as type 2 diabetes,8 cancer,9 premature mortality,10 and CVD,11 both as a direct risk factor as well as a risk for other CVRFs, such as high cholesterol and hypertension.

Obesity has been steadily raising in the last few decades and in particular among older adults12 and although an increasing body of evidence suggests that overweight (25< BMI < 30) in older adults could be more protective than normal weight in terms of overall mortality,13 a link has also been established between excess of fat body mass and cognitive impairment.14 A recent systematic review and meta-analysis of observational studies conducted on a total of about 600,000 individuals showed that obesity (but not overweight) at midlife increases the risk of dementia (RR, 1.33; 95% confidence interval [CI], 1.08–1.63).15

It has been suggested that weight loss could reduce indirectly the risk of dementia by improving a variety of metabolic factors linked with the pathogenesis of cognitive impairment and dementia (i.e. glucose tolerance, insulin sensitivity, blood pressure, oxidative stress, and inflammation).16 However, a direct beneficial effect of weight reduction intervention is also plausible. Although, so far, evidence of potential cognitive benefits of weight loss seem to be strongly associated with increased physical activity,17,18 in 2011 a systematic review on overweight obese people concluded that intentional weight loss can improve performance in some cognitive domains, at least in obese people.19

This review of systematic reviews was carried out to search, identify, and synthesise the evidence currently available on the efficacy of lifestyle/behavioural and/or pharmacological interventions aimed at weight loss in people overweight or obese in reducing the risk of dementia and/or cognitive impairment.

Part 1. Evidence review

Scoping questions in PICO format (population intervention, comparisons, outcome)

For adults with normal cognition or mild cognitive impairment who are overweight or obese, are interventions for weight reduction (or control of obesity) more effective than usual care or no intervention in reducing the risk of cognitive decline and/or dementia?

P: Adults with normal cognition or mild cognitive impairment who are overweight or obese

I: Weight management

-

Non-pharmacological interventions: e.g. cognitive-behavioural intervention strategies, lifestyle interventions;

-

Pharmacological interventions: e.g. weight-loss medication (e.g. orlistat)

C: Care as usual or no intervention

O: Critical

Cognitive function (or cognitive test results using validated instruments)

Incident MCI

Dementia

Important

Quality of life

Functional level (ADL, IADL)

Adverse events

Drop-out rates

Search Strategy

Date of search: 25th of April 2018

Search starting time: 31st December 2012

Full search terms

(dementia OR cognit* OR mild cognitive impairment OR Alzheimer disease OR dementia vascular OR dementia multi-infarct OR MCI OR cognitive dysfunction OR neuropsychologi* OR Health-Related Quality Of Life OR life quality OR Activities, Daily Living OR Chronic Limitation of Activity OR Limitation of Activity, Chronic OR ADL OR activities of daily living OR Drug-Related Side Effects and Adverse Reactions OR Adverse Drug Event OR Adverse Drug Reaction OR Long Term Adverse Effects OR Adverse Effects, Long Term Disease-Free Survival OR Event-Free Survival OR Adverse effects) AND (Overweight OR Body weight or Body mass index OR weight loss OR Body weight changes) AND (Behavior OR behaviour OR drug therapy OR pharmacologic therapy OR pharmacotherapy OR Cognitive behavioural therapy OR Cognitive behavioural therapy OR Drug therapy OR cognitive therapy OR online therapy OR treatment OR Appetite depressants)

Simplified search terms

(dementia OR MCI OR cognition OR Quality Of Life OR ADL OR Adverse Effects OR Drop-out) AND overweight AND weight reduction

Searches were conducted in the following databases1:

Cochrane

Pubmed

NICE Guidelines

Embase

PsycInfo

Global Health Library (Including WHOLIS, PAHO, AIM, LILACS)

Database of impact evaluations

AFROLIB

ArabPsycNet

HERDIN NeON

HrCak

IndMED

KoreaMed

AJOL

List of systemic reviews identified by the search process

Included in GRADE2 tables:

Comparison: Behavioural and/or lifestyle intervention vs usual care or no intervention

Veronese N, Facchini S, Stubbs B, Luchini C, Solmi M, Manzato E, Sergi G, Maggi S, Cosco T, Fontana L. Weight Loss is associated with improvements in cognitive function among overweight and obese people: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2017 Jan;72:87–94. [PubMed: 27890688]

Comparison: Pharmacological intervention vs placebo or no intervention

No Reviews nor individual RCTs of pharmacological-based interventions, which also included outcomes related to dementia and/or cognitive decline, were identified.

PICO Table

Serial NumberIntervention/ComparisonOutcomesSystematic reviews used for GRADEJustification for systematic review used
1Lifestyle intervention vs. usual care or no interventionIncidence of dementiaNo relevant systematic review available.N/A
MCINo relevant systematic review available.N/A
Cognitive functionVeronese N, Facchini S, Stubbs B, Luchini C, Solmi M, Manzato E, Sergi G, Maggi S, Cosco T, Fontana L. Weight loss is associated with improvements in cognitive function among overweight and obese people: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2017 Jan;72:87–94.Very Recent (2017), moderate quality systematic review assessing the effect of intentional weight loss on cognitive outcomes and meta-analysis on RCTs testing the effect of lifestyle intervention aimed at weight loss on 5 cognitive domains
Quality of LifeNo relevant systematic review available.N/A
Functional levels (ADL)No relevant systematic review available.N/A
Adverse eventsNo relevant systematic review available.N/A
Dropout RatesNo relevant systematic review available.N/A
2Pharmacological intervention vs. placebo or no interventionIncidence of dementiaNo relevant systematic review available.N/A
MCINo relevant systematic review available.N/A
Cognitive functionNo relevant systematic review available.N/A
Quality of LifeNo relevant systematic review available.N/A
Functional levels (ADL)No relevant systematic review available.N/A
Adverse eventsNo relevant systematic review available.N/A
Dropout RatesNo relevant systematic review available.N/A

Narrative descriptions of the studies that went into the analysis

GRADE table 1

Based on the hypothesis that weight loss could improve cognition in obese or overweight individuals, Veronese et al.20 carried out a systematic review and meta-analysis aimed to investigate the effect of intentional weight loss on cognitive status in this population across observational and interventional studies. Extensive search and screening of the literature, which included several major healthcare databases, was conducted by two authors (Veronese N and Facchini S) independently from inception to 02.01.2016. The review included only studies that: included participants with a BMI of at least 25; reported only about intentional weight loss; assessed cognition through validated scales; reported at least 2 kg of weight loss (i.e. clinically significant weight loss19) in the treated group between follow-up and baseline; and included only a lifestyle/beahvioural intervention (pharmacological treatments were not included).

Data extraction was also carried out by two authors (SM and LC) independently and the results at follow-up evaluation of any cognitive tests assessed through validated scales were used as outcomes. Cognitive tests were categorised in five domains: attention; executive function; memory; motor speed; language domains.

After screening and assessment of the 1250 records obtained, seven randomised controlled trials (RCTs) were considered eligible and included in the meta-analysis.2127 The studies included a total of 328 participants randomised to treated groups (262 in a dietary intervention group, 26 treated with physical activity, and 40 with both intervention components). In particular, the RCTs had a variety of interventions: four were based on diet alone,21,22,25,26 one on diet and physical activity,24 one on caloric restriction and physical activity,23 and one on caloric restriction or unsaturated fatty acid enhancement (in two different arms).27 Participants were followed up for a median of 20 weeks (range: 8–48). Based on the neuropsychological tests administered in each trial, the meta-analysis for each of the cognitive domains was included a sub-group of the seven RCTs selected. In the review a formal and quantitative assessment of both heterogeneity (Q2 and I2 statistics) and publication bias (Egger’s test) was conducted.

In the meta-analysis a significant improvement of the attention domain (four studies included)21,22,24,25 was reported (SMD = 0.44; 95%CI: 0.26–0.62, p < 0.0001) and the Egger’s test did not detect any publication bias. Heterogeneity, however, results high (I2= 60%). A significant improvement was also found in the memory domain (6 studies included2123,2426; SMD = 0.35; 95%CI: 0.12–0.57, p = 0.002). However heterogeneity was also high (I2= 64%) and significant publication bias detected (Egger’s test = 3.72 ± 0.68; p = 0.004), likely due to the inclusion of studies reporting negative findings. After a trim and fill procedure, the SMD increased to 0.61 (95%CI: 0.37–0.86). Language was the last cognitive domain to provide significant results (SMD = 0.21; 95%CI:0.05–0.37, p = 0.009). However, the highest heterogeneity rate was detected among the four studies included21,2426 in this meta-analysis (I2= 73%) and publication bias was also detected, but in this case the trim and fill procedure did not change the results (SMD = 0.32; 95%CI:0.03–0.61). Two domains did not show any significant results: executive function and motor speed (SMD = −0.00; 95%CI: −0.30–0.37, p < 0.97; and SMD = 0.17; 95%CI: −0.14–0.48, p < 0.28, respectively). Both analysis were carried out on 2 studies (although the authors did not provide information on what specific studies were included) and although no high heterogeneity was identified (I2=41% and 12%, respectively) quantitative analysis of publication bias was not possible.

Main limitations of the studies were related to publication bias and heterogeneity (moderate to high), as well as a small sample size for the assessment of two outcomes. Furthermore, the mean duration of the intervention was relatively short and no formal assessment of dropout rates and/or adverse events was identified. The authors also reported that the effect of weight loss on cognition appeared to be not moderated by the baseline BMI, suggesting that a beneficial effect of weight loss in both overweight and obese people. Lack of studies and RCTs that the impact of weight loss on dementia and Alzheimer’s disease outcomes was identified.

Additional Evidence

The evidence (low to moderate quality), obtained from the analysis of the systematic review, indicates a small, but nonetheless significant, beneficial effect of lifestyle interventions aimed at weight reduction, in both overweight and obese people, on cognition in the attention, memory, and language domains, in particular.

The evidence included in GRADE is partially confirmed by an older (2011) systematic review and meta-analysis, published by Siervo and colleagues,28 aimed at assessing the effect of intentional weight loss reported on cognitive function in overweight and obese people. Twelve trials (seven randomised and five non-randomised) were included in this study. Key inclusion criteria were: 1. statistically significant and intentional weight loss greater than 2 kg (considered as clinically meaningful) and likely association with improvements in metabolic and vascular functions; and 2. reported assessment of cognitive function before and after weight loss through standardised and validated neuropsychological tests. A small size significant effect of weight loss was found for memory (SMD 0.13, 95% CI 0.00–0.26, P = 0.04) and attention/executive functioning (SMD 0.14, 95% CI 0.01–0.27, P < 0.001). However, the association between weight loss and cognitive improvements was identified only in obese but not in overweight individuals. The quality of the evidence was mostly limited by heterogeneity and publication bias both formally assessed with standardised tests.

In addition to this, a body of observational evidence generally supports a role for overweight and obesity in increasing the risk of cognitive impairment, and highlight age-based difference on such effect.

In 2014, Prickett et al. examined the relationship between obesity and cognitive function in a systematic review of cross-sectional and/or prospective studies.29 The review included studies on adults between 18 and 65 years of age, with a BMI of at least 30, with concurrent assessment of cognitive function. Evidence from the 17 studies that were identified and included showed a significant association between obesity and cognitive impairment across almost all the cognitive domains investigated (complex attention, verbal and visual memory, decision making). However the quality of the evidence was hampered by methodological limitations identified in the studies considered (e.g. matching or handling of confounders, variability in the study design, use of appropriate comparison groups, incomplete investigation of the cognitive domains) as well as publication bias due to challenges in publishing non-significant results.

On the following year, Xu and colleagues published a Meta-analysis on risk and protective factors for Alzheimer’s disease (AD).30 PubMed and the Cochrane database of systematic reviews were systematically searched from inception to July 2014 for cohort studies and retrospective case–control studies reporting on risk factors for AD and dementia. Studies were included if: they reported original data concerning odds ratio (OR) or risk ratio (RR) of AD using a longitudinal cohort study or retrospective case–control study design; the study population was representative of the general population and; modifiable risk factors were included. A total of 323 papers were included in the meta-analysis. Concerning BMI, Grade I evidence indicated that its influences the risk of AD are complex and depend on age: high BMI in mid-life would increase the risk of the disease while high BMI in late life would be protective.

Pedditizzi et al. (2016) conducted a systematic review of epidemiological longitudinal studies, published from inception since September 201431 that reported on incidence of AD/dementia and cognitive function, as well as data related to overweight and obesity. The search was conducted on a range of relevant databases and studies had at least 2 years follow up and included an assessment of incident dementia and 21 studies met the selection criteria. The meta-analysis, which included 13 studies, showed that obesity below the age of 65 was associated with a higher risk of dementia (RR 1.41, 95% CI 1.20–1.66), but the opposite was seen in those aged 65 and over (RR 0.83, CI: 0.74–0.94).

In the same year, Lafortune et al carried out a rapid systematic review on the midlife risk factors associated with dementia.32 Longitudinal cohort studies were searched in several relevant databases starting from 2000 and 164 were included in the qualitative synthesis. Weight change/weight cycling was one of the risk factors considered, but the authors identified only limited evidence suggesting that weight changes (in both directions) in midlife is associated with an increase of dementia.

Finally, in 2017 Hersi et al. published a systematic review and qualitative synthesis of risk factors associated with progression to AD.33 The authors searched for both primary observational studies and systematic reviews. Eleven systematic reviews and six primary studies that reported on the association between obesity and body mass index (BMI) with risk of AD, were identified. Overall the evidence from the synthesis of the included publications was inconclusive, although differences based on age were identified.

WHO guidelines for general population

The WHO guidance on overweight and obesity as per the “Prevention and control of noncommunicable diseases: Guidelines for primary health care in low-resource settings (2012)” (http://www.who.int/nmh/publications/phc2012/en/)

  • Advise overweight patients to reduce weight by following a balanced diet.
  • Advise patients to give preference to low glycaemic-index foods (beans, lentils, oats and unsweetened fruit) as the source of carbohydrates in their diet.
  • Advise patients to reduce sedentary behaviour and practice regular daily physical activity appropriate for their physical capabilities (e.g. walking).

GRADE Tables

GRADE table 1

Author(s): Mariagnese Barbera; Jenni Kulmala

Date:

Question: Behavioural and/or lifestyle interventions for weight reduction (or control of obesity) compared to usual care or no intervention for reducing risk of dementia and/or cognitive decline

Setting:

Bibliography: Veronese N, Facchini S, Stubbs B, Luchini C, Solmi M, Manzato E, Sergi G, Maggi S, Cosco T, Fontana L. Weight Loss is associated with improvements in cognitive function among overweight and obese people: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2017 Jan;72:87–94 [PubMed: 27890688].

Certainty assessment№ of patientsEffectCertaintyImportance
№ of studiesStudy designRisk of biasInconsistencyIndirectnessImprecisionOther considerationsBehavioural and/or lifestyle interventions for weight reduction (or control of obesity)usual care or no intervention

Relative

(95% CI)

Absolute

(95% CI)

Cognition Attention (follow up: mean 20 weeks; assessed with: a range of neurpsychological tests; Scale from: N/A to N/A)1
4randomised trialsnot seriousseriousanot seriousnot seriousnone222104-

SMD 0.44 SD higher

(0.26 higher to 0.62 higher)

⨁⨁⨁◯

MODERATE

CRITICAL
Cognition Executive Function (follow up: range 12 weeks to 48 weeks; assessed with: a range of neuropsychological tests; Scale from: N/A to N/A)
2randomised trialsnot seriousnot seriousnot seriousseriousbnone9956-

SMD 0 SD

(0.38 lower to 0.37 higher)

⨁⨁⨁◯

MODERATE

CRITICAL
Cognition Memory (follow up: mean 14 weeks; assessed with: a range of neuropsychological tests; Scale from: N/A to N/A)2
6randomised trialsnot seriousseriouscnot seriousnot seriouspublication bias strongly suspectedd236113-

SMD 0.35 SD higher

(0.12 higher to 0.57 higher)

⨁⨁◯◯

LOW

CRITICAL
Cognition Motor Speed (follow up: N/A; assessed with: a range of neurpsychological tests; Scale from: N/A to N/A)3
2randomised trialsnot seriousnot seriousnot seriousseriousbnone11750-

SMD 0.17 SD higher

(0.14 lower to 0.48 higher)

⨁⨁⨁◯

MODERATE

CRITICAL
Cognition Language (follow up: mean 22 weeks; assessed with: a range of neuropsychological tests)4
4randomised trialsnot seriousseriousenot seriousnot seriouspublication bias strongly suspectedf222104-

SMD 0.21 SD higher

(0.05 higher to 0.37 higher)

⨁⨁◯◯

LOW

CRITICAL

CI: Confidence interval; SMD: Standardised mean difference

Explanations

a

Downgraded due to high heterogeneity (I2=60).

b

Downgraded due to small sample size.

c

Downgraded due to high heterogeneity (I2=64).

d

Downgraded due to publication bias identified through Egger’s test likely due to the inclusion of studies reporting negative findings. A trim and fill procedure increased the SMD to 0.61 (95%CI: 0.37–0.86) with 3 studies trimmed.

e

Downgraded due to high heterogeneity (I2=75).

f

Downgraded due to publication bias identified through Egger’s test. In this case, the trim and fill procedure did not change the results (SMD = 0.32; 95%CI:0.03–0.61).

Definition of interventions

1

Four studies included: three = diet-based interventions; one = diet + physical activity intervention

2

Two studies included both with diet-based interventions

3

Six studies included: four = diet-based interventions; one = caloric restriction + physical activity intervention; one = caloric restriction OR unsaturated fatty acid intervention

4

Two studies included: one = diet based intervention; one = diet + physical activity intervention

5

Four studies included: three = diet-based interventions; one = diet + physical activity intervention

Part 2. From evidence to recommendations

Summary of Findings

Behavioural and/or lifestyle interventions for weight reduction (or control of obesity) compared to usual care or no intervention for reducing risk of dementia and/or cognitive decline

Patient or population: reducing risk of dementia and/or cognitive decline

Setting:

Intervention: Behavioural and/or lifestyle interventions for weight reduction (or control of obesity)

Comparison: usual care or no intervention

OutcomesAnticipated absolute effects* (95% CI)Relative effect (95% CI)№ of participants (studies)Certainty of the evidence (GRADE)Comments
Risk with usual care or no interventionRisk with Behavioural and/or lifestyle interventions for weight reduction (or control of obesity)

Cognition Attention (Attention)

assessed with: a range of neuropsychological tests

Scale from: N/A to N/A

follow up: mean 20 weeks

-

SMD 0.44 SD higher

(0.26 higher to 0.62 higher)

-

326

(4 RCTs)1

⨁⨁⨁◯

MODERATEa

Weight reduction (or control of obesity) seems to improve attention.

Cognition Executive Function (Executive Function)

assessed with: a range of neuropsychological tests

Scale from: N/A to N/A

follow up: range 12 weeks to 48 weeks

-

SMD 0 SD

(0.38 lower to 0.37 higher)

-

155

(2 RCTs)2

⨁⨁⨁◯

MODERATEb

Weight reduction (or control of obesity) does not seem to improve executive function.

Cognition Memory (Memory)

assessed with: a range of neuropsychological tests

Scale from: N/A to N/A

follow up: mean 14 weeks

-

SMD 0.35 SD higher

(0.12 higher to 0.57 higher)

-

349

(6 RCTs)3

⨁⨁◯◯

LOWc,d

Weight reduction (or control of obesity) seems to improve memory.

Cognition Motor Speed (Motor Speed)

assessed with: a range of neuropsychological tests

Scale from: N/A to N/A

follow up: N/A

-

SMD 0.17 SD higher

(0.14 lower to 0.48 higher)

-

167

(2 RCTs)4

⨁⨁⨁◯

MODERATEb

Weight reduction (or control of obesity) does not seem to improve motor speed.

Cognition Language (Language)

assessed with: a range of neuropsychological tests

follow up: mean 22 weeks

-

SMD 0.21 SD higher

(0.05 higher to 0.37 higher)

-

326

(4 RCTs)5

⨁⨁◯◯

LOWe,f

Weight reduction (or control of obesity) seems to improve language.
*

The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). Higher SMD = better cognitive performance.

CI: Confidence interval; SMD: Standardised mean difference

GRADE Working Group grades of evidence

High certainty: We are very confident that the true effect lies close to that of the estimate of the effect

Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different

Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect

Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

Explanations

a

Downgraded due to high heterogeneity (I2=60).

b

Downgraded due to small sample size.

c

Downgraded due to high heterogeneity (I2=64).

d

Downgraded due to publication bias identified through Egger’s test likely due to the inclusion of studies reporting negative findings. A trim and fill procedure increased the SMD to 0.61 (95%CI: 0.37–0.86) with 3 studies trimmed.

e

Downgraded due to high heterogeneity (I2=75).

f

Downgraded due to publication bias identified through Egger’s test. In this case, the trim and fill procedure did not change the results (SMD = 0.32; 95%CI:0.03–0.61).

Definition of interventions

1

Four studies included: three = diet-based interventions; one = diet + physical activity intervention

2

Two studies included both with diet-based interventions

3

Six studies included: four = diet-based interventions; one = caloric restriction + physical activity intervention; one = caloric restriction OR unsaturated fatty acid intervention

4

Two studies included: one = diet based intervention; one = diet + physical activity intervention

5

Four studies included: three = diet-based interventions; one = diet + physical activity intervention

Evidence to Decision Table

Download PDF (729K)

Reference

1.
Alzheimer´s Disease International. World Alzheimer Report 2015. The global impact of dementia: An analysis of prevalence, incidence, cost and trends. https://Www​.alz.co.uk​/research/WorldAlzheimerReport2015.pdf. 2015.
2.
Norton S, Matthews FE, Brayne C. A commentary on studies presenting projections of the future prevalence of dementia. BMC Public Health. 2013;13:1-2458-13-1. [PMC free article: PMC3547813] [PubMed: 23280303]
3.
Winblad B, Amouyel P, Andrieu S, et al. Defeating Alzheimer’s disease and other dementias: A priority for European science and society. Lancet Neurol. 2016;15(5):455–532. [PubMed: 26987701]
4.
Solomon A, Mangialasche F, Richard E, et al. Advances in the prevention of Alzheimer’s disease and dementia. J Intern Med. 2014;275(3):229–250. [PMC free article: PMC4390027] [PubMed: 24605807]
5.
Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement. 2007; 3, 186–191. [PubMed: 19595937]
6.
Jagger C, Matthews R, Lindesay J, Robinson T, Croft P, Brayne C. The effect of dementia trends and treatments on longevity and disability: a simulation model based on the MRC Cognitive Function and Ageing Study (MRC CFAS). Age Ageing. 2009; 38, 319–25; discussion 251. [PubMed: 19258397]
7.
8.
Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fatdistribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17, 961–969. [PubMed: 7988316]
9.
Renehan AG, Zwahlen M, Egger M. Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat. Rev. Cancer. 2015;15 (August (8)),484–498. [PubMed: 26205341]
10.
Fontana L, Hu FB. Optimal body weight for health and longevity: bridging basic, clinical, and population research. Aging cell. 2014;13, 391–400. [PMC free article: PMC4032609] [PubMed: 24628815]
11.
Eckel RH. Obesity and heart disease: a statement for healthcare professionals from the nutrition committee, American heart association. Circulation. 1997;96, 3248–3250. [PubMed: 9386201]
12.
Nguyen DM, El-Serag HB. The epidemiology of obesity. Gastroenterol. Clin. North Am. 2010;39, 1–7. [PMC free article: PMC2833287] [PubMed: 20202574]
13.
Flicker L, McCaul KA, Hankey GJ, Jamrozik K, Brown WJ, Byles JE, Almeida OP. Body mass index and survival in men and women aged 70 to 75. J Am Geriatr Soc. 2010;58, 234–241. [PubMed: 20370857]
14.
Xu WL, Att, AR, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology. 2011;76, 1568–1574. [PMC free article: PMC3100125] [PubMed: 21536637]
15.
Albanese E, Launer LJ, Egger M, Prince MJ, Giannakopoulos P, Wolters FJ, Egan K. Body mass index in midlife and dementia: Systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies. Alzheimers Dement (Amst). 2017 Jun 20;8:165–178. [PMC free article: PMC5520956] [PubMed: 28761927]
16.
Bennett S, Grant MM, Aldred S. Oxidative stress in vascular dementia and Alzheimer’s disease: a common pathology. J. Alzheimer’s Disease: JAD. 2009;17, 245–257. [PubMed: 19221412]
17.
Colcombe SJ, Erickson KI, Scalf PE, Kim JS, Prakash R, McAuley E, Elavsky S, Marquez DX, Hu L, Kramer AF. Aerobic exercise training increases brain volume in aging humans. J. Gerontol. Series A Biol. Sci. Med. Sci. 2006;61, 1166–1170. [PubMed: 17167157]
18.
Erickson KI, Raji CA, Lopez OL, Becker JT, Rosano C, Newman AB, Gach HM, Thompson PM, Ho AJ, Kuller LH. Physical activity predicts gray matter volume in late adulthood: the cardiovascular health study. Neurology. 2010;75, 1415–1422. [PMC free article: PMC3039208] [PubMed: 20944075]
19.
Siervo M, Arnold R, Wells JCK, Tagliabue A, Colantuoni A, Albanese E, Brayne C, Stephan BCM. Intentional weight loss in overweight and obese individuals and cognitive function: a systematic review and meta-analysis. Obes. Rev. 2011;12, 968–983. [PubMed: 21762426]
20.
Veronese N, Facchini S, Stubbs B, Luchini C, Solmi M, Manzato E, Sergi G, Maggi S, Cosco T, Fontana L. Weight Loss is associated with improvements in cognitive function among overweight and obese people: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2017 Jan;72:87–94. [PubMed: 27890688]
21.
Bryan J, Tiggemann M. The effect of weight-loss dieting on cognitive performance and psychological well-being in overweight women. Appetite. 2001; 36, 147–156. [PubMed: 11237350]
22.
Green MW, Elliman NA. Are dieting-related cognitive impairments a function of iron status? Br. J. Nutr. 2012;1–9. [PubMed: 22414889]
23.
Martin CK, Anton SD, Han H, York-crowe E, Leanne M. Examination of cognitive function during six months of calorie restriction: results of a randomized controlled trial. Rejuvenation Res. 2009;10, 179–190. [PMC free article: PMC2664681] [PubMed: 17518698]
24.
Napoli N, Shah K, Waters DL, Sinacore DR, Qualls C, Villareal DT. Effect of weight loss, exercise, or both on cognition and quality of life in obese older adults. Am. J. Clin. Nutr. 2014;100, 189–198 [PMC free article: PMC4144098] [PubMed: 24787497]
25.
Prehn K, Jumpertz von Schwartzenberg R, Mai R, Zeitz U, Witte AV, Hampel D, Szela AM, Fabian S, Grittner U, Spranger J, Floel A. 2016a. Caloric restriction in older adults—differential effects of weight loss and reduced weight on brain structure and function. Cereb. Cortex, 2017 Mar 1;27(3):1765–1778. [PubMed: 26838769]
26.
Smith PJ, Blumenthal JA, Babyak MA, Craighead L, Welsh-Bohmer KA, Browndyke JN, Strauman TA, Sherwood A. Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. Hypertension. 2010;55, 1331–1338. [PMC free article: PMC2974436] [PubMed: 20305128]
27.
Witte AV, Fobker M, Gellner R, Knecht S, Flöel A. Caloric restriction improves memory in elderly humans. Proc. Natl. Acad. Sci. 2009;106, 1255–1260. [PMC free article: PMC2633586] [PubMed: 19171901]
28.
Siervo M, Arnold R, Wells JCK, Tagliabue A, Colantuoni A, Albanese E, Brayne C, Stephan BCM. Intentional weight loss in overweight and obese individuals and cognitive function: a systematic review and meta-analysisobr_903 968. Obesity Reviews 2011; 12, 968–983. [PubMed: 21762426]
29.
Prickett C, Brennan L, Stolwyk R. Examining the relationship between obesity and cognitive function: A systematic literature review. Obesity Research & Clinical Practice. 2015; 9, 93—113. [PubMed: 25890426]
30.
Xu W, Tan L, Wang HF, Jiang T, Tan MS, Tan L, Zhao QF, Li JQ, Wang J, Yu JT. Meta-analysis of modifiable risk factors for Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1299–306. [PubMed: 26294005]
31.
Pedditizzi E, Peters R, Beckett N. The risk of overweight/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies. Age and Ageing. 2016; 45: 14–21. [PubMed: 26764391]
32.
Lafortune L, Martin S, Kelly S, Kuhn I, Remes O, Cowan A, Brayne C. Behavioural Risk Factors in Mid-Life Associated with Successful Ageing, Disability, Dementia and Frailty in Later Life: A Rapid Systematic Review. PLoS One. 2016 Feb 4;11(2):e0144405. [PMC free article: PMC4742275] [PubMed: 26845035]
33.
Hersi M, Irvine B, Gupta P, Gomes J, Birkett N, Krewski D. Risk factors associated with the onset and progression of Alzheimer’s disease: A systematic review of the evidence. Neurotoxicology. 2017 Jul;61:143–187. [PubMed: 28363508]
34.
Filippatos TD, Derdemezis CS, Gazi IF, Nakou ES, Mikhailidis DP, Elisaf MS. Orlistat-associated adverse effects and drug interactions: a critical review. Drug Saf. 2008;31(1):53–65. [PubMed: 18095746]
35.
Cheng S. Dementia Caregiver Burden: a Research Update and Critical Analysis. Curr Psychiatry Rep. 2017; 19(9): 64. [PMC free article: PMC5550537] [PubMed: 28795386]
36.
Mougias AA, Politis A, Mougias MA, Kotrotsou I, Skapinakis P, Damigos D, Mavreas VG. The burden of caring for patients with dementia and its predictors. Psychiatriki. 2015 Jan-Mar;26(1):28–37. [PubMed: 25880381]
37.
Finkelstein EA, Kruger E. Meta- and cost-effectiveness analysis of commercial weight loss strategies. Obesity (Silver Spring). 2014 Sep;22(9):1942–51. [PubMed: 24962106]
38.
Leahey TM, Fava JL, Seiden A, Fernandes D, Doyle C, Kent K, La Rue M, Mitchell M, Wing RR. A randomized controlled trial testing an Internet delivered cost-benefit approach to weight loss maintenance. Prev Med. 2016 Nov;92:51–57. [PMC free article: PMC5067166] [PubMed: 27095323]
39.
Goettler A, Grosse A, Sonntag D. Productivity loss due to overweight and obesity: a systematic review of indirect costs. BMJ Open. 2017 Oct 5;7(10):e014632. [PMC free article: PMC5640019] [PubMed: 28982806]
40.
UCL Institute of Health Equity; Inequality in mental health, cognitive impairment and dementia among older people. 2016.
41.
Thies W, Bleiler L. 2013 Alzheimer’s disease facts and figures. Alzheimer’s Dement. 2013;9(2):208–245. [PubMed: 23507120]
42.
Varnado-Sullivan PJ, Savoy S, O’Grady M, Fassnacht G. Opinions and acceptability of common weight-loss practices. Eat Weight Disord. 2010 Dec;15(4):e256–64. [PubMed: 21406949]

Annex. PRISMA3 flow diagram for systematic review of the reviews – cognitive decline interventions3

Image evidenceprofile7app1f1

Footnotes

1

Please note that the EurasiaHealth database did not return any meaningful answer to the search.

2

GRADE: Grading of Recommendations Assessment, Development and Evaluation. More information: http:​//gradeworkiggroup.org

3

Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). For more information: http://www​.prisma-statement.org

© World Health Organization 2019.

Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing.

Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user.

Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo).

Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services.

The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”.

Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.

Bookshelf ID: NBK542803

Views

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...